Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lung Diseases × Nivolumab × Clear all

Phase

Phase 2 2 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 5 Kidney Neoplasms 4 Carcinoma, Renal Cell 4 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Thoracic Neoplasms 1 Skin Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Diseases 1 Liver Neoplasms 1

Interventions

Carboplatin 2 Vinorelbine 1 Pemetrexed 1 Paclitaxel 1 One-Lung Ventilation 1 Nivolumab 1 Natriuretic Peptide, Brain 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05583188 2024-07-19

VIGOR

Galvanize Therapeutics, Inc.

Phase 4 Terminated

Lung Diseases, Lung Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡